|Fludarabine and rituximab for relapsed or refractory hairy cell leukemia|
AS Gerrie, LN Zypchen, JM Connors
Blood 119 (9), 1988-1991, 2012
|D (T) PACE as salvage therapy for aggressive or refractory multiple myeloma|
AS Gerrie, JR Mikhael, L Cheng, H Jiang, V Kukreti, T Panzarella, ...
British journal of haematology 161 (6), 802-810, 2013
|Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma|
AS Gerrie, MM Power, JD Shepherd, KJ Savage, LH Sehn, JM Connors
Annals of oncology 25 (11), 2218-2223, 2014
|Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia|
KH Xing, A Kahlon, BF Skinnider, JM Connors, RD Gascoyne, LH Sehn, ...
British journal of haematology 169 (4), 520-527, 2015
|Outcome of patients with non-Hodgkin lymphomas with concurrent MYC and BCL2 rearrangements treated with CODOX-M/IVAC with rituximab followed by hematopoietic stem cell …|
H Sun, KJ Savage, A Karsan, GW Slack, RD Gascoyne, CL Toze, ...
Clinical Lymphoma Myeloma and Leukemia 15 (6), 341-348, 2015
|Rituximab with high‐dose methotrexate in primary central nervous system lymphoma|
R Kansara, TN Shenkier, JM Connors, LH Sehn, KJ Savage, AS Gerrie, ...
American journal of hematology 90 (12), 1149-1154, 2015
|Phase 2 trial of interim PET scan-tailored therapy in patients with advanced stage diffuse large B-cell lymphoma (DLBCL) in British Columbia (BC)|
LH Sehn, ELG Hardy, KK Gill, AJ Al-Tourah, J Shustik, NA Macpherson, ...
Blood 124 (21), 392-392, 2014
|Observation as the initial management strategy in patients with mantle cell lymphoma|
P Abrisqueta, DW Scott, GW Slack, C Steidl, A Mottok, RD Gascoyne, ...
Annals of Oncology 28 (10), 2489-2495, 2017
|Diffuse large B‐cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era|
R Kridel, D Telio, D Villa, LH Sehn, AS Gerrie, T Shenkier, R Klasa, ...
British journal of haematology 176 (2), 210-221, 2017
|Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials|
AS Gerrie, CL Toze, KM Ramadan, CH Li, J Sutherland, A Yee, ...
Leukemia & lymphoma 53 (1), 77-82, 2012
|Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free survival time points and survival comparison with the general population in British Columbia|
G Hapgood, Y Zheng, LH Sehn, D Villa, R Klasa, AS Gerrie, T Shenkier, ...
Journal of Clinical Oncology 34 (21), 2493-2500, 2016
|Preservation of lower incidence of chronic lymphocytic leukemia in Chinese residents in British Columbia: a 26-year survey from 1983 to 2008|
V Mak, D Ip, O Mang, C Dalal, S Huang, A Gerrie, T Gillan, KM Ramadan, ...
Leukemia & lymphoma 55 (4), 824-827, 2014
|Advanced stage classical Hodgkin lymphoma patients with a negative PET-scan following treatment with ABVD have excellent outcomes without the need for consolidative …|
KJ Savage, JM Connors, DR Villa, G Hapgood, AS Gerrie, TN Shenkier, ...
Blood 126 (23), 579-579, 2015
|Outcome of patients with double-hit lymphomas treated with CODOX-M/IVAC+ R followed by hematopoietic stem cell transplantation in British Columbia|
KJ Savage, A Karsan, GW Slack, CL Toze, LH Sehn, YRA Mourad, ...
Blood 122 (21), 1788-1788, 2013
|I gG4‐related disease with hypergammaglobulinemic hyperviscosity and retinopathy|
PCW Wong, AT Fung, AS Gerrie, G Moloney, D Maberley, D Rossman, ...
European journal of haematology 90 (3), 250-256, 2013
|Allogeneic hematopoietic stem cell transplantation is an effective salvage therapy for patients with chronic myeloid leukemia presenting with advanced disease or failing …|
AP Nair, MJ Barnett, RC Broady, DE Hogge, KW Song, CL Toze, ...
Biology of Blood and Marrow Transplantation 21 (8), 1437-1444, 2015
|Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia|
B Lee, O Goktepe, K Hay, JM Connors, LH Sehn, KJ Savage, T Shenkier, ...
The oncologist 19 (3), 283-290, 2014
|Prognostic model to predict post-autologous stem-cell transplantation outcomes in classical Hodgkin lymphoma|
FC Chan, A Mottok, AS Gerrie, M Power, M Nijland, A Diepstra, ...
J Clin Oncol 35 (32), 3722-3733, 2017
|Site of central nervous system (CNS) relapse in patients with diffuse large B‐cell lymphoma (DLBCL) by the CNS‐IPI risk model|
R Kansara, D Villa, AS Gerrie, R Klasa, T Shenkier, DW Scott, GW Slack, ...
British journal of haematology 179 (3), 508-510, 2017
|Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma|
K Hay, B Lee, O Goktepe, JM Connors, LH Sehn, KJ Savage, R Klasa, ...
Leukemia & lymphoma 57 (2), 276-282, 2016